Drug intelligence / Profile preview

collagenase I

Development stage
Unknown
Lead developer
Endo International
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Topical, Injection (local, Intralesional)
01

Overview

Collagenase I is a proteolytic enzyme primarily derived from the bacterium *Clostridium histolyticum*. It specifically cleaves the peptide bonds in triple-helical regions of native collagen types I, II, and III, leading to the breakdown of collagen within connective tissues. These enzymatic activities make collagenase I useful for the enzymatic debridement of necrotic tissue in burns or chronic skin ulcers (topical: Santyl), as well as in some tissue dissociation protocols. Collagenase derived from *Clostridium histolyticum* is also the biological basis for approved pharmaceutical products (such as Xiaflex and Qwo) developed for the injection-based treatment of Dupuytren's contracture, Peyronie's disease, and cellulite. The enzyme acts by hydrolyzing collagen fibers, decomposing pathological collagen build-ups.

Brand names
Santyl
Other names
collagenasecollagenase type Iclostridial collagenasebacterial collagenasecollagenase clostridium histolyticumcollagenase clostridiopeptidase A
02

Targets

COL1 (Collagen type I)COL2 (Type II Collagen)

Beyond the preview

Go deeper on collagenase I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on collagenase I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call